XML 65 R53.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 30, 2023
Nov. 30, 2022
Sep. 30, 2022
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Proceeds from issuance of common stock           $ 496 $ 2,107    
Stock based compensation           2,001 1,289    
Equity Option [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Stock based compensation       $ 200 $ 100 400 300    
Unrecognized compensation costs       1,800   $ 1,800      
Remaining contractual term           4 years      
Intrinsic value of options outstanding       18   $ 18      
Intrinsic value of options exercisable       $ 200   $ 200      
Options vested           355,034      
Options unvested       348,624   348,624      
Restricted Stock Units (RSUs) [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Stock units outstanding, RSUs           35,625      
Weighted average grant date fair values           $ 13.05      
Performance Stock Units [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Stock units outstanding, RSUs           142,500      
RSUs And PSUs [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Stock based compensation       $ 300   $ 900      
Remaining contractual term           5 months      
Unrecognized restricted stock grant expense       $ 500   $ 500      
Restricted Stock [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Stock based compensation           $ 400 $ 300    
Remaining contractual term           3 months      
Options unvested       14,808   14,808     1,238
Weighted average grant date fair values           $ 6.20      
Unvested shares of common stock       $ 100   $ 100      
Warrant [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Weighted average remaining contractual life           3 years 6 months      
Intrinsic value exercisable shares warrants       $ 0   $ 0      
Warrants purchase       282,334   282,334      
Warrants exercised price, per share           $ 6.30      
B Riley Purchase Agreement [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Stock issued new, shares 10,484   10,484     281,157      
Proceeds from issuance of common stock           $ 3,000      
Offering costs           $ 500      
B Riley Capital [Member] | Common Stock Purchase Agreement [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Stock issued new, shares               281,157  
Proceeds from sale of equity               $ 3,000  
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Restricted stock units granted   142,500              
Chief Executive Officer [Member] | Performance Stock Units [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Restricted stock units granted   142,500              
Consultant [Member] | Investor Relations Services [Member] | Warrant [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Warrants issued, shares           200,000      
Fair value of warrants issued           $ 1,600      
Warrant expense           $ 200